Worst performer was RAT:Rathbones, dropping 18% after announcing a series of measures following an FCA assessment of their operation. It will hit profits, but not by 18% so I'm hoping they will recover.
CKN:Clarkson dropped 9%, presumably because things are easing up in the Middle East and much of the recent rise has been off the back of the complexities with shipping out there.
PAGE:Pagegroup continue their decline, with a 9% drop for no obvious reason. My holding is now 78% down, making this one of my worst performing magic formula shares.
BTG:BTG Consulting fell 7%, possibly due to people thinking the ceasefire in the Middle East will improve the economy to the detriment of BTG. I don't think that's the case, so may use this as an opportunity to buy more when my next pension transfer comes through.
OPTI:Optibiotix fell another 5% and there's no sign of anything changing.
RIO:Rio Tinto was the worst of the miners, dropping 5% when the rest were either flat or reasonably up.
EDV:Endeavour Mining went up 5%, and ATYM:Atalya Mining 6% but mid-week they were up by twice that.
AMP:Ampeak Energy climbed 8% for no obvious reason, but my holding is still 64% down.
GGP:Greatland Resources was the best of the miners, climbing 10% to go 94% up.
IES:Invinity Energy zoomed up 22% after another contract was announced.
SBTX:SkinBioTherapeutics dropped badly after being removed from suspension last week, but this week climbed 38% presumably on hopes that one day Croda might sell something.
I'm awarding Share of the Week to TAM:Tatton Asset Management. They climbed 18% which is amazing for a magic formula share. This was on the back of final results significantly exceeding expectations. I'm hopeful this has much further to run.
Here's the ISA and shares portfolio after week 47 of year 11.
| Weekly Change | |||
| Cash | £105.81 | -£3.92 | |
| Portfolio cost | £116,490.29 | +£0 | |
| Portfolio sell value (bid price-commission) | £32,109.85 | (-72.4%) | +£578.37 |
| Potential profits | £444.34 | +£92.82 | |
| Yr 11 Dividends | £86.83 | +£0 | |
| Yr 11 Interest | £1.57 | +£0 | |
| Yr 11 Profit from sales | £873.14 | +£0 | |
| Yr 11 proj avg monthly profit | £80.73 | (1.1%) | -£2.13 |
| Total Dividends | £12,574.90 | +£0 | |
| Total Interest | £10.14 | +£0 | |
| Total Profit from sales | £18,433.41 | +£0 | |
| Average monthly cash profit | £232.08 | (3.2%) | -£0.44 |
| (Sold stocks profit + Dividends - Fees / Months) |
Still pretty flat.
Back up almost on the trend line
The SIPP looks like this after week 551 overall and week 31 of year 11.
| Weekly Change | ||||
| Cash | £854.29 | +£40.14 | ||
| Portfolio cost | £160,213.80 | +£0 | ||
| Portfolio sell value (bid price - commission) | £89,606.55 | (-44.1%) | +£7.68 | |
| Potential profits | £10,730.71 | +£278.66 | ||
| Yr 11 Dividends | £1.477.07 | +£44.41 | ||
| Yr 11 Interest | £12.26 | +£0 | ||
| Yr 11 Profit from sales | £9,397.72 | +£0 | ||
| Yr 11 proj avg monthly profit | £1,503.45 | (18.2%) | -£44.32 | |
| Total Dividends | £19,697.27 | +£44.41 | ||
| Total Interest | £32.96 | +£0 | ||
| Total Profit from sales | £34,064.23 | +£0 | ||
| Average monthly cash profit | £409.28 | (5.0%) | -£0.43 |
Cash was up thanks to a £6 dividend from PAGE:Pagegroup and £37 from YU.:Yu Group, minus monthly fees. Portfolio value was just about as flat as it could be, but potential profits increased £278 mostly thanks to TAM:Tatton Asset Management.
I had a feeling I was never going to close the gap to the injection line, and that does seem to be the case.
Still well below the trend line.
Leaving the trend line behind here too.
I'm not terribly optimistic about things getting better in the Middle East, given Israel are acting as if there's no ceasefire. Markets will continue to fluctuate wildly so I may as well just accept the fact there's not likely to be any recovery in my portfolio value for the rest of the summer at least.
